New SEC Form D filing
Cloverleaf Bio, Inc., 2026-09-09
A new SEC Form D private-offering notice from New Haven, CT, a $29,599,977 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
RNA therapeutics company developing engineered tRNA based treatments for cancer, spun out of Yale University
New filing todayFiled to raise $29,599,977First money in 2026-08-24Raised so far $14,799,988HQ (as filed) New Haven, CTSector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Call-ready
Source linked the Form D on EDGAR↗Website verified cloverleafbio.com↗Named in the filing 5 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Capital Engine Inc., 2026-09-04, $5M, Stamford, CT
- Iambic Therapeutics, Inc., 2026-09-09, $66.5M, San Diego, CA
- AMERICAN HALAL COMPANY, PBC, 2026-09-04, $10.1M, Stamford, CT
- Animal Biosciences, Inc., 2026-09-09, $2.6M, Boston, MA
- Pantera, Inc., 2026-09-03, $3.5M, Hartford, CT
- Airway Therapeutics, Inc., 2026-09-09, $50.6M, Marietta, GA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.